34th week of 2021 patent applcation highlights part 25 |
Patent application number | Title | Published |
20210261552 | ERK INHIBITOR AND USE THEREOF | 2021-08-26 |
20210261553 | FUSED TETRAZOLES AS LRRK2 INHIBITORS | 2021-08-26 |
20210261554 | RIPK2 INHIBITORS AND METHOD OF TREATING CANCER WITH SAME | 2021-08-26 |
20210261555 | FUSED PYRIMIDINE DERIVATIVES AS A2A / A2B INHIBITORS | 2021-08-26 |
20210261556 | SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS | 2021-08-26 |
20210261557 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | 2021-08-26 |
20210261558 | METHOD FOR PREPARING 2-INDOLINOSPIRONE COMPOUND AND INTERMEDIATE THEREOF | 2021-08-26 |
20210261559 | 1,5-DISUBSTITUTED 1,2,3-TRIAZOLES ARE INHIBITORS OF RAC/CDC42 GTPASES | 2021-08-26 |
20210261560 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | 2021-08-26 |
20210261561 | BICYCLIC HETEROCYCLE DERIVATIVES HAVING SELECTIVE BACE1 INHIBITORY ACTIVITY | 2021-08-26 |
20210261562 | CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF | 2021-08-26 |
20210261563 | TRICYCLIC P2-LIGAND CONTAINING POTENT HIV-PROTEASE INHIBITORS AGAINST HIV/AIDS | 2021-08-26 |
20210261564 | POLYCYCLIC COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS | 2021-08-26 |
20210261565 | NOVEL SESQUITERPENOID ANALOGS | 2021-08-26 |
20210261566 | MACROCYCLIC COMPOUND AND USES THEREOF | 2021-08-26 |
20210261567 | METHODS FOR TREATMENT OF HEART FAILURE | 2021-08-26 |
20210261568 | SULFONYLUREA COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY | 2021-08-26 |
20210261569 | FUSED HETEROCYCLIC DERIVATIVES HAVING SELECTIVE BACE1 INHIBITORY ACTIVITY | 2021-08-26 |
20210261570 | ANTIBIOTIC RESISTANCE BREAKERS | 2021-08-26 |
20210261571 | INTERMEDIATES IN THE SYNTHESIS OF C3-SUBSTITUTED CEPHALOSPORINS | 2021-08-26 |
20210261572 | ANTICANCER INDENES, INDANES, AZAINDENES, AZAINDANES, PHARMACEUTICAL COMPOSITIONS AND USES | 2021-08-26 |
20210261573 | COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY | 2021-08-26 |
20210261574 | BORON-CONTAINING SMALL MOLECULES | 2021-08-26 |
20210261575 | AMINOSILYL-FUNCTIONALIZED CONJUGATED DIENES, THEIR PREPARATION AND THEIR USE IN THE PRODUCTION OF RUBBERS | 2021-08-26 |
20210261576 | DEGRADABLE SILANE HAVING THIO AND AMINO GROUPS, SILICIC ACID POLYCONDENSATES AND HYBRID POLYMERS PRODUCED THEREFROM, USE THEREOF AND METHOD FOR PRODUCING THE SILANES | 2021-08-26 |
20210261577 | TITANIUM HETEROMETALLIC METAL-ORGANIC SOLIDS, METHOD FOR OBTAINING THEM AND THEIR USES | 2021-08-26 |
20210261578 | LONG-WAVE ABSORBING PHOTOINITIATORS | 2021-08-26 |
20210261579 | PRODRUGS OF NALTREXONE, NALMEFENE AND DERIVATIVES THEREOF | 2021-08-26 |
20210261580 | ANTIBIOTICS FOR VETERINARY STAPHYLOCOCCAL INFECTIONS | 2021-08-26 |
20210261581 | ACYLPHOSPHINEOXIDE INITIATORS | 2021-08-26 |
20210261582 | AZITHROMYCIN DERIVATIVES CONTAINING A PHOSPHONIUM ION AS ANTICANCER AGENTS | 2021-08-26 |
20210261583 | Synthetic Cytotoxic Molecules, Drugs, Methods of Their Synthesis and Methods of Treatment | 2021-08-26 |
20210261584 | Base-Modified Cytidine Nucleotides for Leukemia Therapy | 2021-08-26 |
20210261585 | Alvocidib Prodrugs Having Increased Bioavailability | 2021-08-26 |
20210261586 | BIPHENYL TETRADENTATE PHOSPHITE COMPOUND PREPARATION METHOD AND APPLICATION THEREOF | 2021-08-26 |
20210261587 | STRAD-binding agents and Uses Thereof | 2021-08-26 |
20210261588 | SPIRO-CONTAINING PLATINUM(II) EMITTERS WITH TUNABLE EMISSION ENERGIES AND SYNTHESES THEREOF | 2021-08-26 |
20210261589 | FLUORINATED PORPHYRIN DERIVATIVES FOR OPTOELECTRONIC APPLICATIONS | 2021-08-26 |
20210261590 | PROCESS FOR ISOLATING LIGNIN FROM AN ALKALINE PROCSS STREAM | 2021-08-26 |
20210261591 | TREHALOSE ANALOGUES | 2021-08-26 |
20210261592 | BIARYL AMIDES WITH MODIFIED SUGAR GROUPS FOR TREATMENT OF DISEASES ASSOCIATED WITH HEAT SHOCK PROTEIN PATHWAY | 2021-08-26 |
20210261593 | TERPENE GLYCOSIDE DERIVATIVES AND USES THEREOF | 2021-08-26 |
20210261594 | USE OF AVERMECTIN DERIVATIVE FOR INCREASING BIOAVAILABILITY AND EFFICACY OF MACROCYLIC LACTONES | 2021-08-26 |
20210261595 | PRODUCTION METHOD FOR GUANOSINE DERIVATIVE HAVING FLUORINE ATOM-CONTAINING FUNCTIONAL GROUP AT POSITION 8 AND APPLICATION THEREOF | 2021-08-26 |
20210261596 | METHOD FOR PREPARING OLIGONUCLEIC ACID COMPOUND | 2021-08-26 |
20210261597 | COMPOSITIONS AND METHODS FOR SYNTHESIZING 5'-CAPPED RNAS | 2021-08-26 |
20210261598 | OXYSTEROLS AND METHODS OF USE THEREOF | 2021-08-26 |
20210261599 | Process for the Preparation of Obeticholic Acid and Intermediates Used In the Process Thereof | 2021-08-26 |
20210261600 | Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof | 2021-08-26 |
20210261601 | METHOD FOR PURIFYING CRUDE ROCURONIUM BROMIDE | 2021-08-26 |
20210261602 | (PYRIDINYLMETHYL)BUTANEDIAMINE DERIVATIVES THAT CHELATE COPPER | 2021-08-26 |
20210261603 | SITE-SPECIFIC SERINE ADP-RIBOSYLATED PROTEINS AND PEPTIDES AND METHOD FOR PRODUCING THE SAME | 2021-08-26 |
20210261604 | COMPOSITIONS FOR ACTIVE IMMUNOTHERAPY | 2021-08-26 |
20210261605 | Fc-BINDING PROTEIN EXHIBITING IMPROVED ALKALINE RESISTANCE, METHOD FOR PRODUCING SAID PROTEIN, ANTIBODY ADSORBENT USING SAID PROTEIN, AND METHOD FOR SEPARATING ANTIBODY USING SAID ANTIBODY ADSORBENT | 2021-08-26 |
20210261606 | AFFINITY CARRIER USING MUTANT VHH ANTIBODY | 2021-08-26 |
20210261607 | PURIFICATION OF CHIMERIC FVIII MOLECULES | 2021-08-26 |
20210261608 | Methods for Extracting Proteins from a Blood-Based Material | 2021-08-26 |
20210261609 | NEOANTIGENS EXPRESSED IN OVARIAN CANCER AND THEIR USES | 2021-08-26 |
20210261610 | METHOD FOR PRODUCING AMIDE | 2021-08-26 |
20210261611 | HEMIASTERLIN DERIVATIVES FOR CONJUGATION AND THERAPY | 2021-08-26 |
20210261612 | LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT | 2021-08-26 |
20210261613 | AROMATIC-CATIONIC PEPTIDES AND USES OF SAME | 2021-08-26 |
20210261614 | NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS | 2021-08-26 |
20210261615 | PEPTIDE COMPOUNDS AND THERAPEUTIC USES OF SAME | 2021-08-26 |
20210261616 | Compounds with Antimicrobial Properties | 2021-08-26 |
20210261617 | Compstatin Analogs with Increased Solubility and Improved Pharmacokinetic Properties | 2021-08-26 |
20210261618 | SYNTHETIC PEPTIDE SP2 AND APPLICATION THEREOF | 2021-08-26 |
20210261619 | APELIN POLYPEPTIDES | 2021-08-26 |
20210261620 | PEPTIDE LIGANDS FOR BINDING TO EphA2 | 2021-08-26 |
20210261621 | Preparation of Dilipid Polymixins and Use Thereof as Antimicrobial Adjuvants | 2021-08-26 |
20210261622 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | 2021-08-26 |
20210261623 | THETA DEFENSIN ANALOGS AND METHODS OF USE | 2021-08-26 |
20210261624 | RUBELLA VIRUS SPIKE CONSTRUCT | 2021-08-26 |
20210261625 | MODIFIED ADENO-ASSOCIATED VIRAL CAPSID PROTEINS FOR OCULAR GENE THERAPY AND METHODS OF USE THEREOF | 2021-08-26 |
20210261626 | GENETICALLY ENCODED POLYPEPTIDE FOR AFFINITY CAPTURE AND PURIFICATION OF BIOLOGICS | 2021-08-26 |
20210261627 | RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE | 2021-08-26 |
20210261628 | MODULAR DNA-BINDING DOMAINS AND METHODS OF USE | 2021-08-26 |
20210261629 | FUCOSE-BINDING PROTEIN, METHOD FOR PRODUCING SAME, AND USE OF SAME | 2021-08-26 |
20210261630 | ANTI-GRAM-NEGATIVE BACTERIAL COMPOUND | 2021-08-26 |
20210261631 | Compositions and Methods for Control of Insect Pests | 2021-08-26 |
20210261632 | MODIFIED FORM OF OLEOSIN THAT WHEN EXPRESSED IN PLANTS LEADS TO INCREASED TRIACYLGYCEROL (OIL) ACCUMULATION | 2021-08-26 |
20210261633 | MUTATED TAU PROTEIN FRAGMENT AND USE THEREOF | 2021-08-26 |
20210261634 | LIGHT-INDUCIBLE PROTEIN AGGREGATION SYSTEM FOR MODELING PROTEINOPATHIES AND NEURODEGENERATIVE DISORDERS | 2021-08-26 |
20210261635 | COMPOSITIONS AND METHODS FOR USING ACTIN-BASED PEPTIDES TO MODULATE CELLULAR BIOACTIVITY AND CELLULAR SUSCEPTIBILITY TO INTRACELLULAR PATHOGENS | 2021-08-26 |
20210261636 | NEOANTIGENS EXPRESSED IN MULTIPLE MYELOMA AND THEIR USES | 2021-08-26 |
20210261637 | MODIFIED FGF-21 POLYPEPTIDES AND THEIR USES | 2021-08-26 |
20210261638 | PERIOSTIN COMPOUNDS FOR THE TREATMENT OF HAEMATOLOGICAL COMPLICATIONS | 2021-08-26 |
20210261639 | COMPOSITIONS COMPRISING AN INTERLEUKIN CONSTRUCT | 2021-08-26 |
20210261640 | COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES AND DISORDERS | 2021-08-26 |
20210261641 | NOVEL COMPOUNDS FOR TREATMENT OF OBESITY | 2021-08-26 |
20210261642 | SOLUBILITY OF GLP-1 PEPTIDE | 2021-08-26 |
20210261643 | INHIBITORS OF P-TEFB MEDIATED TRANSCRIPTION | 2021-08-26 |
20210261644 | PD-1-BASED VACCINES AGAINST CORONAVIRUS INFECTION | 2021-08-26 |
20210261645 | BISPECIFIC T CELL ENGAGER AND USES THEREOF | 2021-08-26 |
20210261646 | CHIMERIC RECEPTORS IN COMBINATION WITH TRANS METABOLISM MOLECULES ENHANCING GLUCOSE IMPORT AND THERAPEUTIC USES THEREOF | 2021-08-26 |
20210261647 | LAMP CONSTRUCTS COMPRISING ALLERGENS | 2021-08-26 |
20210261648 | FCgammaRIIB-SPECIFIC FC REGION VARIANT | 2021-08-26 |
20210261649 | COMPOSITIONS AND METHODS FOR ANTIBODY DELIVERY | 2021-08-26 |
20210261650 | ANTIBODIES AGAINST SARS-COV-2 AND METHODS OF USING THE SAME | 2021-08-26 |
20210261651 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE | 2021-08-26 |